Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care, Biosensors & Mobile Diagnostics Europe 2019

Vincent Linder's Biography



Vincent Linder, Founder and President, CDP BioMedical Consulting

BioMedical Consultant, Entrepreneur & Senior Biotech Executive with track record of success for biomedical devices. Partner with clients for value creation during all aspects of development of biomedical devices, from invention to commercialization.

Co-founder of Claros Diagnostics (a technology company spun out of Harvard University) with a successful $50M exit, completion of design & development activities, CE-mark and submission to FDA of a pre-market approval (PMA) as Chief Technology Officer of OPKO Diagnostics. The Claros® device is a point-of-care device that allows the quantitative determination of protein by immunoassay in a droplet of fingerstick blood. Technical and regulatory oversight for the launch of the 4Kscore®, a blood test for the early detection of prostate cancer.

Post-doctoral fellow at Harvard University (Prof. Whitesides), and Ph.D. in Switzerland from the Institute of Microtechnology, University of Neuchatel (Prof. de Rooij), in collaboration with the Insel University Hospital, and CSEM (Swiss Center of Electronics and Microtechnology).

Vincent Linder Image

Commercialization of Microfluidic Devices for Point-of-Care Applications

Tuesday, 18 June 2019 at 14:15

Add to Calendar ▼2019-06-18 14:15:002019-06-18 15:15:00Europe/LondonCommercialization of Microfluidic Devices for Point-of-Care ApplicationsPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

This presentation will focus on the commercialization challenges specific to microfluidic devices for point-of-care applications.  At an early stage of development, strategies can focus on de-risking analytical and clinical performances and may overlook other critical aspects of the design.  For a successful commercialization effort, it is essential to implement at the onset of the program a comprehensive vision encompassing the patient presenting in a POC setting, the POC user and all the steps needed to obtain an actionable test result.  This presentation will focus on selected commercialization challenges and discuss directions/solutions to overcome them.


Add to Calendar ▼2019-06-18 00:00:002019-06-19 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2019Point-of-Care, Biosensors and Mobile Diagnostics Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com